XIAP-targeting drugs re-sensitize PIK3CA-mutated colorectal cancer cells for death receptor-induced apoptosis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Cell Death and Disease (2014) 5, e1570; doi:10.1038/cddis.2014.534
- Schlagwort
-
Krebs
Onkologie
- Ereignis
-
Veröffentlichung
- (wo)
-
Würzburg
- (wer)
-
Universität Würzburg
- (wann)
-
2015
- Urheber
-
Ehrenschwender, M.
Bittner, S.
Seibold, K.
Wajant, H.
- URN
-
urn:nbn:de:bvb:20-opus-114374
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ehrenschwender, M.
- Bittner, S.
- Seibold, K.
- Wajant, H.
- Universität Würzburg
Entstanden
- 2015
Ähnliche Objekte (12)
Aspirin sensitivity of PIK3CA-mutated Colorectal Cancer: potential mechanisms revisited
Multiple PIK3CA mutation clonality correlates with outcomes in taselisib + fulvestrant-treated ER+/HER2–, PIK3CA-mutated breast cancers
Apoptosis-unrelated functions of XIAP during melanoma development
PIK3CA is recurrently mutated in canine mammary tumors, similarly to in human mammary neoplasia
Small molecule XIAP inhibitors enhance γ-irradiation-induced-apoptosis [Gamma-irradiation-induced-apoptosis] in glioblastoma
Understanding PI3K/Akt/mTOR signaling in squamous cell carcinoma: mutated PIK3CA as an example
Combining small molecule XIAP inhibitors and death receptor ligands as promising approach to overcome apoptosis resistance in acute and chronic lymphocytic leukemia
Carcinogenesis of PIK3CA
Antitumor activity of the PI3K δ-sparing inhibitor MEN1611 in PIK3CA mutated, trastuzumab-resistant HER2 + breast cancer
Systemic network analysis identifies XIAP and IκBα as potential drug targets in TRAIL resistant BRAF mutated melanoma
Characterization of the role of XIAP in modulating inflammatory death and its consequences
The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by Phenoxodiol is associated with Carboplatin sensitization
Aspirin sensitivity of PIK3CA-mutated Colorectal Cancer: potential mechanisms revisited
Multiple PIK3CA mutation clonality correlates with outcomes in taselisib + fulvestrant-treated ER+/HER2–, PIK3CA-mutated breast cancers
Apoptosis-unrelated functions of XIAP during melanoma development
PIK3CA is recurrently mutated in canine mammary tumors, similarly to in human mammary neoplasia
Small molecule XIAP inhibitors enhance γ-irradiation-induced-apoptosis [Gamma-irradiation-induced-apoptosis] in glioblastoma
Understanding PI3K/Akt/mTOR signaling in squamous cell carcinoma: mutated PIK3CA as an example
Combining small molecule XIAP inhibitors and death receptor ligands as promising approach to overcome apoptosis resistance in acute and chronic lymphocytic leukemia
Carcinogenesis of PIK3CA
Antitumor activity of the PI3K δ-sparing inhibitor MEN1611 in PIK3CA mutated, trastuzumab-resistant HER2 + breast cancer
Systemic network analysis identifies XIAP and IκBα as potential drug targets in TRAIL resistant BRAF mutated melanoma
Characterization of the role of XIAP in modulating inflammatory death and its consequences
The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by Phenoxodiol is associated with Carboplatin sensitization
Aspirin sensitivity of PIK3CA-mutated Colorectal Cancer: potential mechanisms revisited
Multiple PIK3CA mutation clonality correlates with outcomes in taselisib + fulvestrant-treated ER+/HER2–, PIK3CA-mutated breast cancers
Apoptosis-unrelated functions of XIAP during melanoma development
PIK3CA is recurrently mutated in canine mammary tumors, similarly to in human mammary neoplasia
Small molecule XIAP inhibitors enhance γ-irradiation-induced-apoptosis [Gamma-irradiation-induced-apoptosis] in glioblastoma
Understanding PI3K/Akt/mTOR signaling in squamous cell carcinoma: mutated PIK3CA as an example
Combining small molecule XIAP inhibitors and death receptor ligands as promising approach to overcome apoptosis resistance in acute and chronic lymphocytic leukemia
Carcinogenesis of PIK3CA
Antitumor activity of the PI3K δ-sparing inhibitor MEN1611 in PIK3CA mutated, trastuzumab-resistant HER2 + breast cancer
Systemic network analysis identifies XIAP and IκBα as potential drug targets in TRAIL resistant BRAF mutated melanoma
Characterization of the role of XIAP in modulating inflammatory death and its consequences